Autologous Bone Marrow Mononuclear Cells
C/ICPD/2007
Phase 2 other completed
Quick answer
Autologous Bone Marrow Mononuclear Cells for Peripheral Vascular Diseases is a Phase 2 program (other) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Peripheral Vascular Diseases
- Phase
- Phase 2
- Modality
- other
- Status
- completed